March 18-21, 2025: 44th Annual International Symposium on Intensive Care and Emergency Medicine (ISICEM) - BioAegis Therapeutics

Skip to content

HOME
ABOUT US
OUR SCIENCE
OUR PLATFORM
NEWS/EVENTS
PUBLICATIONS
CONTACT

HOME
ABOUT US
OUR SCIENCE
OUR PLATFORM
NEWS/EVENTS
PUBLICATIONS
CONTACT

March 18-21, 2025: 44th Annual International Symposium on Intensive Care and Emergency Medicine (ISICEM)

Stay informed of our latest discoveries and news.

EMAIL

GENERAL NEWS/MEDIA

October 17, 2024: BioAegis Therapeutics Enrolls First Patient in Phase 2 Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

October 17, 2024

September 12, 2024: BioAegis Therapeutics to Present at Upcoming MedInvest Biotech & Pharma Investor Conference in NYC

September 12, 2024

February 27, 2024: BioAegis Therapeutics Unveils Upcoming Clinical Study of Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)

February 27, 2024

EVENTS

March 27-28, 2025: MedInvest Biotech & Pharma Investor Conference

March 18-21, 2025: 44th Annual International Symposium on Intensive Care and Emergency Medicine (ISICEM)

COMPANY DETAILS

LOCATION:
BioAegis Therapeutics
685 US Route 1
North Brunswick, NJ 08902

MEDIA INQUIRIES:
Contact: Christine Lagana
clagana@bioaegistx.com

INVESTOR INQUIRIES:
Contact: Steven Cordovano
scordovano@bioaegistx.com

JOIN OUR TEAM

PRODUCT FAQS

FOLLOW US

Twitter Linkedin Youtube Medium

©2024 BioAegis® Therapeutics Inc.
Privacy Policy | Code of Business Conduct and Ethics | Terms of Use